Update of influenza vaccine strains in Europe. Quality issues by A. A. Soldatov, Zh. I. Avdeeva, V. P. Bondarev

Get full text

General Considerations on Clinical Trials of Hemophilia Medicines by Zh. I. Avdeeva, A. A. Soldatov, V. P. Bondarev, V. A. Merkulov

Get full text

Authorisation of Non-Innovator Biotherapeutic (Biosimilar) Products in the USA by A. A. Soldatov, Zh. I. Avdeeva, V. P. Bondarev, V. D. Mosyagin

Get full text

Current regulatory requirements for clinical trials of viral vaccines by A. A. Soldatov, D. V. Gorenkov, Zh. I. Avdeeva, V. A. Merkulov

Get full text

General Characteristics of Adjuvants and Their Mechanism of Action (Part 1) by N. A. Alpatova, Zh. I. Avdeeva, S. L. Lysikova, O. V. Golovinskaya, L. A. Gayderova

Get full text

Orphan drugs and the principles of their marketing authorization procedures and clinical use by A. A. Soldatov, Zh. I. Avdeeva, N. A. Alpatova, N. V. Medunitsyn, S. L. Lysikova

Get full text

Immune Response Induced by Immunisation with Antiviral Vaccines by N. A. Alpatova, Zh. I. Avdeeva, L. A. Gayderova, S. L. Lysikova, N. V. Medunitsyn

Get full text

Factor VIII products: key aspects of development, clinical research and use (part 1) by Zh. I. Avdeeva, A. A. Soldatov, V. P. Bondarev, V. D. Mosyagin, V. A. Merkulov

Get full text

Factor VIII products: key aspects of development, clinical research and use (part 2) by Zh. I. Avdeeva, A. A. Soldatov, V. P. Bondarev, V. D. Mosyagin, V. A. Merkulov

Get full text

Current regulatory requirements for non-clinical evaluation of prophylactic vaccines by D. V. Gorenkov, E. I. Komarovskaya, A. A. Soldatov, Zh. I. Avdeeva, V. P. Bondarev

Get full text

The safety of biological preparations. Part 2. Safety issues of biosimilars by A. A. Soldatov, Zh. I. Avdeeva, Yu. V. Olefir, V. A. Merkulov, V. P. Bondarev

Get full text

Safety of biological preparations. Report 1. Terminology and classification issues by A. A. Soldatov, Zh. I. Avdeeva, Yu. V. Olefir, V. A. Merkulov, V. P. Bondarev

Get full text

Challenges in development and authorisation of gene therapy products by A. A. Soldatov, Zh. I. Avdeeva, D. V. Gorenkov, L. M. Khantimirova, S. G. Guseva, V. A. Merkulov

Get full text

General characteristics of adjuvants and their mechanisms of action (part 2) by N. А. Alpatova, Zh. I. Avdeeva, S. L. Lysikova, O. V. Golovinskaya, L. A. Gayderova, V. P. Bondarev

Get full text

Pharmacokinetic properties of the preparations of protein origin by A. A. Soldatov, Zh. I. Avdeeva, N. A. Alpatova, N. V. Medunitsyn, S. L. Lysikova, V. A. Merkulov

Get full text

Assessment of biotechnological products specific activity by N. A. Alpatova, L. A. Gayderova, A. K. Yakovlev, E. V. Motuzova, S. L. Lysikova, A. A. Soldatov, Zh. I. Avdeeva

Get full text

Modern biological/biotechnological medicinal products. Topical issues and prospects for development by Yu. V. Olefir, N. V. Medunitsyn, Zh. I. Avdeeva, A. A. Soldatov, A. A. Movsesyants, V. A. Merkulov, V. P. Bondarev

Get full text

Russian and International Regulatory Recommendations for the Development and Marketing Authorisation of COVID-19 Vaccines in the Context of the Pandemic by A. A. Soldatov, Zh. I. Avdeeva, V. P. Bondarev, V. A. Merkulov, V. D. Mosyagin, V. B. Ivanov, D. V. Gorenkov, L. M. Khantimirova

Get full text

Preparations of next generation monoclonal antibodies (issues and prospects) by Zh. I. Avdeeva, A. A. Soldatov, N. A. Alpatova, N. V. Medunitsyn, V. P. Bondarev, A. N. Mironov, V. A. Merkulov, I. V. Sakaeva

Get full text

First available biosimilar monoclonal antibodies by Zh. I. Avdeeva, A. A. Soldatov, N. A. Alpatova, V. P. Bondarev, Yu. V. Olefir, V. A. Merkulov, V. D. Mosyagin, N. V. Medunitsyn

Get full text